Related Experiment Video
Updated: Nov 2, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Transition of patients with interstitial lung disease from paediatric to adult care
Václav Koucký1, Petr Pohunek1, Martina Vašáková2
1Paediatric Pulmonology, Paediatric Dept, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
Insights
Transitioning children with interstitial lung disease to adult care is inconsistent and inadequate across most centers. A new model procedure is proposed to improve patient information transfer and preparation for adult care.
Area of Science:
- Medical Research
- Public Health
- Pediatric Pulmonology
Background:
- The European Cooperation in Science and Technology (COST) Action CA16125 established a network for translational research in interstitial lung diseases (ILDs).
- Working Group 5 specifically addressed the critical transition of pediatric patients with ILDs to adult care systems.
- Current transition processes are often fragmented, lacking standardized protocols for information exchange and patient preparation.
Purpose of the Study:
- To evaluate the existing systems for transitioning pediatric patients with ILDs to adult care.
- To identify deficiencies and inconsistencies in current transition practices.
- To develop a model procedure to standardize and improve the transition process.
Main Methods:
- A survey was conducted among members of COST Action CA16125 Working Group 5 and affiliated specialists.
- The survey assessed current transition practices, information transfer, and patient preparation protocols.
- Analysis of survey data identified variability and inadequacy in existing transition systems.
Main Results:
- The survey revealed highly variable and inadequate transition systems for pediatric ILD patients to adult care in most centers.
- Most centers lack established, consistent procedures for information transfer and patient preparation.
- Significant deficiencies were noted in preparing patients for the shift to adult specialists and teams.
Conclusions:
- Immediate action is required to address the identified shortcomings in pediatric to adult ILD care transition.
- A model procedure for transition has been developed, drawing on best practices from centers with established pathways.
- The proposed model aims to ensure a smoother, more effective transition for patients with ILDs.
Abstract:
The European Cooperation in Science and Technology (COST) is a funding organisation for the creation of research networks, called COST Actions. COST Action 16125 was dedicated to European network for translational research in children's and adult interstitial lung disease. Working Group 5 of the COST Action CA16125 focussed on the problems of transition of children with interstitial lung diseases from paediatric to adult care. Results of this survey performed among members of the Working Group and some affiliated specialists showed highly variable and inadequate current system of transitions of these patients to adult care in most centres. In most centres there is no established and consistent procedure to guarantee appropriate transfer of information and prepare the patient for transition to a new specialist and a new team. Immediate action is therefore required. The Working Group has prepared a model procedure for the transition, based on protocols from several centres with established pathways, either for childhood interstitial lung disease or other chronic respiratory diseases.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Drug Dosing: Infants and Children
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

